Morgan Stanley
ANRO icon

Morgan Stanley’s Alto Neuroscience ANRO Stock Holding History

Morgan Stanley’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
68,654
+3,073
+5% +$57K ﹤0.01% 4917
2025
Q4 		$1.17M Buy
65,581
+4,545
+7% +$57.2K ﹤0.01% 5100
2025
Q3 		$245K Sell
61,036
-3,594
-6% -$11.9K ﹤0.01% 5809
2025
Q2 		$142K Buy
64,630
+17,823
+38% +$42.4K ﹤0.01% 5990
2025
Q1 		$101K Sell
46,807
-155,834
-77% -$558K ﹤0.01% 5998
2024
Q4 		$857K Buy
202,641
+126,480
+166% +$789K ﹤0.01% 5160
2024
Q3 		$871K Buy
76,161
+49,838
+189% +$610K ﹤0.01% 5122
2024
Q2 		$281K Buy
26,323
+13,038
+98% +$170K ﹤0.01% 5529
2024
Q1 		$204K Buy
+13,285
New +$208K ﹤0.01% 5727

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return